Category Archives: Molecular Medicine

Agilent Technologies Introduces Next-Generation Fluorescent In Situ Hybridization Assays for Molecular Analysis

Agilent Technologies Inc. today introduced Agilent SureFISH probes, the next generation of fluorescent in situ hybridization assays, delivering a comprehensive men Continue reading

Posted in Molecular Medicine | Tagged , , , , , | Comments Off

Basic molecular 'wiring' of stem cells revealed

ScienceDaily (Mar. Continue reading

Posted in Molecular Medicine | Tagged , , , , , , , , , | Comments Off

Randox Molecular Diagnostics Strategy Takes Shape with Pending Launch of Three New Tests

By Ben Butkus Clinical diagnostics firm Randox Laboratories this quarter expects to receive the CE IVD Mark for a trio of multiplex molecular diagnostic panels to detect respiratory pathogens, sexually transmitted infections, and KRAS/BRAF/PIK3CA mutations, a company official said this week. Continue reading

Posted in Molecular Medicine | Tagged , , , , , , , , , , , | Comments Off

Jonathan Stamler named director, Bob Keith to head drug development of Harrington project

CLEVELAND, Ohio Jonathan Stamler, the newly named Director ofUniversity Hospitals Harrington Discovery Institute, was lured from a productive 15-year cardiovascular research career at Duke University in 2009 to head up University Hospitals’ fledgling Institute for Transformational Molecular Medicine. Trained as a cardiologist and pulmonologist (lung doctor) Stamler’s work first made national headlines in 1996 when his lab discovered a new role for hemoglobin, the oxygen-transport protein molecule that gives blood its color. He found that the protein also distributes another gas — nitric oxide — throughout the body. Continue reading

Posted in Molecular Medicine | Tagged , , , , , , , , , , , | Comments Off

Molecular Insight Pharmaceuticals Elects a New Board of Directors

More Topics: Choose a Sector Accounting Firms Advertising/Media/Communications Capital CEO/Board General Business Health/Biotech Internet/Technology Investment Firms Law Firms Mergers & Acquisitions Money Managers People Private Companies Public Companies Venture Capital Posted February 23, 2012 Board Members to Help Guide Restructured Company Toward Prostate Cancer Focused Strategy; Update on Clinical Development Programs CAMBRIDGE, MA — Molecular Insight Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company and pioneer in the field of molecular medicine, announced today that it has elected a new Board of Directors. The new Board will support the Company's strategic focus on the discovery, development, and commercialization of radiopharmaceuticals for molecular imaging and targeted radiotherapy of prostate cancer. Continue reading

Posted in Molecular Medicine | Tagged , , , , , , , , , , , | Comments Off

International meet on molecular medicine begins at SBCE

Small changes in the molecules might cause diseases and discovering new drugs through molecular research was the only solution to address the problem, said Prof V.N. Rajasekharan Pillai, Executive Vice- President and Principal Secretary, Science and Technology Department, Kerala State Council for Science Technology and Environment. Prof Pillai was inaugurating the two-day international conference on molecular medicine that began at Sree Buddha College of Engineering (SBCE) at Pattoor near Pandalam on Thursday. Continue reading

Posted in Molecular Medicine | Tagged , , , , , , , , , , , , | Comments Off

Molecular Insight Pharmaceuticals, Inc. Elects a New Board of Directors

CAMBRIDGE, MA–(Marketwire -02/23/12)- Molecular Insight Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company and pioneer in the field of molecular medicine, announced today that it has elected a new Board of Directors. Continue reading

Posted in Molecular Medicine | Tagged , , , , , , , , , , | Comments Off

Molecular basis of touch sensation: Researchers identify new function of a well-known gene

ScienceDaily (Feb. 21, 2012) — A gene known to control lens development in mice and humans is also crucial for the development of neurons responsible for mechanosensory function, as neurobiologists of the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch have now discovered. They found that in mice in which they had removed the c-Maf gene in the nerve cells, touch sensation is impaired Continue reading

Posted in Molecular Medicine | Tagged , , , , , , , , , , , , | Comments Off

Biocept to Present at the Molecular Medicine Tri-Conference on Circulating Tumor Cell (CTC) Technologies

SAN DIEGO–(BUSINESS WIRE)– Biocept, Inc., a privately-held, CLIA certified laboratory testing company focused on detection and analysis of circulating tumor cells (CTCs) in cancer patients, announced that two of its senior scientists, Farideh Bischoff, Ph.D., Vice President of Translational Research, and Lyle Arnold, Ph.D., Senior Vice President, R&D and Chief Scientific Officer, will be making presentations at the 19th Annual Molecular Medicine Tri-Con being held in San Francisco February 19-23. Dr Continue reading

Posted in Molecular Medicine | Tagged , , , , , , , , , , , , , | Comments Off

UMMS Labs – Video


14-04-2011 08:54 Each year, Advanced Placement Biology students from public high schools and technical schools in Worcester attend UMass Labs for Worcester Area High Schools, the brainchild of Stephen Doxsey, PhD, professor of molecular medicine and biochemistry and molecular pharmacology and cell biology, and North High School science teacher Jane Raabis. The program enables these promising young science students to experience research and biology first-hand by working alongside researchers and using sophisticated equipment in state-of-the-art laboratories at the UMMS campus in Worcester. www.umassmed.edu Continue reading

Posted in Molecular Medicine | Tagged , , , , , , , , | Comments Off

New MDC Research Report published

Public release date: 17-Feb-2012 [ | E-mail | Share ] Contact: bachtler@mdc-berlin.de bachtler@mdc-berlin.de 49-309-406-3896 Helmholtz Association of German Research Centres The Max Delbr?ck Center for Molecular Medicine (MDC) Berlin-Buch, which celebrates its 20th anniversary this year, has published its latest research report. In the 298-page book that is primarily written in English, all of the 67 research groups of the MDC and the clinical groups in the Experimental and Clinical Research Center (ECRC) of the MDC and of the Charit? ? Universit?tsmedizin Berlin give an overview of their work in 2010 ? 2011. Research activities at the MDC focus on cardiovascular and metabolic diseases, cancer, diseases of the nervous system and systems biology Continue reading

Posted in Molecular Medicine | Tagged , , , , , , , , , , , , , | Comments Off

ImmunoCellular Therapeutics To Present at Targeting Stem Cells Symposium during 19th Annual Molecular Medicine Tri …

LOS ANGELES–(BUSINESS WIRE)– ImmunoCellular Therapeutics, Ltd. (“ImmunoCellular” or the “Company”) (OTCBB: IMUC –News), a biotechnology company focused on the development of novel immune-based cancer therapies, today announced that John Yu, MD, Chairman and Chief Scientific Officer of ImmunoCellular Therapeutics, will deliver a presentation at the Cambridge Healthtech Institute’s inaugural Targeting Stem Cells Symposium as a part of the 19th Annual Molecular Medicine Tri-Conference from February 19-23, 2012. Dr. Continue reading

Posted in Molecular Medicine | Tagged , , , , , , , , , , , , , , | Comments Off

Plethora of New Products to be Showcased at 2012 Molecular Medicine Tri-Conference

Needham, MA (PRWEB) February 17, 2012 Cambridge Healthtech Institute announces 47 exhibitors & sponsors to showcase new products at the 19th Molecular Medicine Tri-Conference, taking place February 19-23, at the Moscone North Convention Center, San Francisco, CA. The Molecular Medicine Tri-Conference is the predominant event on the west coast focused on integrating the entire spectrum of drug development. The Molecular Medicine Tri-Conference has experienced seven straight years of attendee growth, while maintaining a high quality audience. Continue reading

Posted in Molecular Medicine | Tagged , , , , , , , , , | Comments Off

On-Q-ity to Present at the Molecular Medicine Tri-Conference

WALTHAM, Mass., Feb. 17, 2012 (GLOBE NEWSWIRE) — On-Q-ity, a life sciences company focused on novel circulating tumor cell (CTC) capture and characterization for clinical researchers and physicians that will enhance decision-making across multiple cancer types, today announced that it will be a corporate sponsor of the Molecular Medicine Tri-Conference being held in San Francisco February 21-23 and will be presenting during the Circulating Tumor Cells Conference Program. Denis Smirnov, Ph.D., Director of Molecular Characterization at On-Q-ity, will be giving a talk on Tuesday, February 21st, on On-Q-ity's CTC platform entitled: “A Microfluidic System for the Selection of Circulating Tumor Cells that Utilizes both Affinity and Size Capture Technologies.” Dr. Continue reading

Posted in Molecular Medicine | Tagged , , , , , , , , , , , , , | Comments Off

SBCE to organise international meet on Molecular Medicine

The Sree Buddha College of Engineering at Pattoor near Pandlam will be organizing a two-day international conference on Molecular Medicine on February 23 and 24. In a statement issued here on Wednesday, Prof K Continue reading

Posted in Molecular Medicine | Tagged , , , , , , , , | Comments Off

Pioneers of molecular research take 2012 Vilcek Prizes in Biomedical Science

Public release date: 15-Feb-2012 [ | E-mail | Share ] Contact: Joyce Li joyce@vilcek.org 212-472-2500 Vilcek Foundation New York, NY — The Vilcek Foundation is pleased to announce the winners of its annual Vilcek Prizes in Biomedical Science, honoring the contributions of foreign-born scientists. Continue reading

Posted in Molecular Medicine | Tagged , , , , , , , , , , , | Comments Off

Research reveals molecular mechanism underlying severe anomalies of the forebrain

Cholesterol has a bad reputation because it may lead to vascular calcification in adults (atherosclerosis) as well as to heart attacks and strokes. However, cholesterol is vital for embryonic development because it controls the development of the central nervous system Continue reading

Posted in Molecular Medicine | Tagged , , , , , , , , , | Comments Off

Scientists identify and describe molecular mechanism behind holoprosencephaly

Researchers of the Max Delbr-ck Center for Molecular Medicine (MDC) Berlin-Buch have now identified and described a molecular mechanism underlying the most common malformation of the brain in humans. Continue reading

Posted in Molecular Medicine | Tagged , , , , , , , , , , , , , , | Comments Off

MDC Researchers Reveal Molecular Mechanism Underlying Severe Anomalies of the Forebrain

14.02.2012 – (idw) Max-Delbr?ck-Centrum f?r Molekulare Medizin (MDC) Berlin-Buch Researchers of the Max Delbr?ck Centrum for Molecular Medicine (MDC) Berlin-Buch have now identified and described a molecular mechanism underlying the most common malformation of the brain in humans. In holoprosencephaly (HPE), the forebrain (prosencephalon) is only incompletely formed Continue reading

Posted in Molecular Medicine | Tagged , , , , , , , , , , , , , , | Comments Off

Molecular secrets behind halofuginone's power

For roughly two thousand years, Chinese herbalists have treated Malaria using a root extract, commonly known as Chang Shan, from a type of hydrangea that grows in Tibet and Nepal. More recent studies suggest that halofuginone, a compound derived from this extract's bioactive ingredient, could be used to treat many autoimmune disorders as well Continue reading

Posted in Molecular Medicine | Tagged , , , , , , , , , , , , , , | Comments Off